![glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]](https://www.2minutemedicine.com/wp-content/uploads/2023/12/2MM_12.18.2023_2_Alisha_GLP1-RA.jpg)
glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]
EUR28.47
EUR67.47
Pay in 4 interest-free payments of $7.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
![glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]](https://scx2.b-cdn.net/gfx/news/2026/glp-1-receptor-agonist-2.jpg)
![glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/363155686/figure/fig1/AS:11431281088240903@1665021834427/GLP-1-receptor-agonists-in-the-treatment-of-type-2-diabetes-e-state-of-the-art-Legend.png)
![glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]](https://www.freece.com/wp-content/uploads/2025/08/AdobeStock_642751321-1024x683.jpeg)
![glp 1 agonists for type 2 diabetes VisualAbstract: Glucagon-like peptide receptor (GLP-1RAs) prescribed are associated with reduced colorectal cancer (CRC) risk compared to other antidiabetic agents glp-1_analogs [TUSOM | Pharmwiki]](https://images.ctfassets.net/4f3rgqwzdznj/2zOOXVnmS5ExpkOMLBGlOZ/9626d72ba81ecfb39b173a74b699ced2/23-02_Comparison_of_GLP-1_Agonist_Drugs.png)
